{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:21:52Z","timestamp":1794255712195,"version":"4.9.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ymgme.2026.110285","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:32:50Z","timestamp":1790688770000},"page":"110285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal audiological findings in mild to moderate Mucopolysaccharidosis type II and potential impact of inner ear dysfunction following blood-brain barrier-penetrating enzyme therapy"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1808-0868","authenticated-orcid":false,"given":"Ayaka","family":"Kise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1164-6977","authenticated-orcid":false,"given":"Tomotaka","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4769-4671","authenticated-orcid":false,"given":"Sei","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6245-8274","authenticated-orcid":false,"given":"Tetsumin","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5226-6183","authenticated-orcid":false,"given":"Motomichi","family":"Kosuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7231-1658","authenticated-orcid":false,"given":"Noriko","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110285_bb0005","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1055\/s-0040-1712107","article-title":"Hearing loss in mucopolysaccharidosis","volume":"25","author":"Bicalho","year":"2021","journal-title":"Int. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.ymgme.2026.110285_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110285_bb0015","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Supplement","key":"10.1016\/j.ymgme.2026.110285_bb0020","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110285_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"Mucopolysaccharidosis type II in females: case report and review of literature","volume":"32","author":"Tuschl","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2026.110285_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2026.110285_bb0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10545-008-0878-x","article-title":"Neurological findings in hunter disease: pathology and possible therapeutic effects reviewed","volume":"31","author":"Al Sawaf","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110285_bb0040","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2026.110285_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2214.1981.tb00838.x","article-title":"Psychosocial problems in Hunter\u2019s syndrome","volume":"7","author":"Young","year":"1981","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.ymgme.2026.110285_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081838","article-title":"Mucopolysaccharidosis type I: a review of the natural history and molecular pathology","volume":"9","author":"Hampe","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymgme.2026.110285_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10080554","article-title":"Hearing loss in mucopolysaccharidoses: current knowledge and future directions","volume":"10","author":"Wolfberg","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.ymgme.2026.110285_bb0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijporl.2005.01.017","article-title":"Otorhinolaryngological manifestations of the mucopolysaccharidoses","volume":"69","author":"Simmons","year":"2005","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.ymgme.2026.110285_bb0065","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/ajmg.a.35498","article-title":"Auditory characteristics and therapeutic effects of enzyme replacement in mouse model of the mucopolysaccharidosis (MPS) II","volume":"158A","author":"Hong","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2026.110285_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A phase 2\/3 trial of Pabinafusp alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110285_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061240","article-title":"Treatment of neuronopathic mucopolysaccharidoses with blood\u2013brain barrier-crossing enzymes: clinical application of receptor-mediated transcytosis","volume":"14","author":"Sonoda","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymgme.2026.110285_bb0080","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1288\/00005537-198307000-00014","article-title":"Reliability and validity of industrial audiometry: implications for hearing conservation program design","volume":"93","author":"Dobie","year":"1983","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ymgme.2026.110285_bb0085","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1080\/14992027.2023.2220909","article-title":"Accuracy of automated pure-tone audiometry in population-based samples of older adults","volume":"63","author":"Hoff","year":"2024","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.ymgme.2026.110285_bb0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/14992020802441799","article-title":"Audiometric shape and presbycusis","volume":"48","author":"Demeester","year":"2009","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.ymgme.2026.110285_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10545-011-9378-5","article-title":"Hearing loss in patients with mucopolysaccharidosis II: data from HOS \u2013 the hunter outcome survey","volume":"35","author":"Keilmann","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110285_bb0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/16512251.1987.12561197","article-title":"Function of the eustachian tube in an alternobaric environment. A study with special reference to the therapy of secretory otitis media in children","volume":"103","author":"Watanabe","year":"1987","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ymgme.2026.110285_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00404152","article-title":"The temporal bone in hunter\u2019s syndrome (gargoylism)","volume":"192","author":"Zechner","year":"1968","journal-title":"Arch. Klin. Exp. Ohren Nasen Kehlkopfheilkd."},{"key":"10.1016\/j.ymgme.2026.110285_bb0110","first-page":"177","article-title":"The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review","volume":"20","author":"Ruckenstein","year":"1991","journal-title":"J. Otolaryngol."},{"key":"10.1016\/j.ymgme.2026.110285_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcomdis.2023.106402","article-title":"Study of the peripheral and central auditory pathways in patients with mucopolysaccharidosis","volume":"107","author":"Chimelo","year":"2024","journal-title":"J. Commun. Disord."},{"key":"10.1016\/j.ymgme.2026.110285_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)","volume":"1","author":"Motas","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2026.110285_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2026.110285_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.841708","article-title":"Hearing function, degeneration, and disease: spotlight on the Stria Vascularis","volume":"10","author":"Thulasiram","year":"2022","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:31:34Z","timestamp":1794252694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1096719226005688"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110285","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal audiological findings in mild to moderate Mucopolysaccharidosis type II and potential impact of inner ear dysfunction following blood-brain barrier-penetrating enzyme therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110285"}}